Bacterial infections of the cornea produce a wide spectrum of clinical signs and symptoms ranging from peripheral and superficial keratitis to central and deep corneal stromal ulcerations. Immediate initiation of specific antimicrobial therapy based on laboratory diagnosis is essential to eradicate the infectious agent and to prevent tissue damage and minimise scarring or melting. [1] [2] [3] Preservation of vision and the integrity of the ocular tissues should be the ultimate goal of therapy in any infectious disease of the cornea.
Over the past two decades the use of topical steroids has increased with a corresponding increase in the risk of acquiring secondary infection by opportunistic bacteria.45 Moreover widespread use of antibiotics may have contributed to the increased incidence of P-lactamase and cephalosporinase pro- 
